Pregnancy-Related Testing
Pregnancy-related testing includes a variety of screening and diagnostic procedures performed before conception, during pregnancy (antenatal/prenatal), and around the time of birth (perinatal). These tests help monitor the health of both the pregnant individual and the developing fetus. The main goal is to identify potential health concerns, such as congenital anomalies, chromosomal abnormalities, genetic disorders, and maternal health conditions that could affect the pregnancy. Screening tests estimate the risk of a condition and are typically non-invasive. A high-risk result from a screening test indicates the need for further, more definitive diagnostic testing. Diagnostic tests provide a clear 'yes' or 'no' answer about whether a specific condition is present. These tests are usually invasive and carry a small risk of complications.
Diagnosis
- Maternal Health Screening (Pre-conception and Initial Prenatal Visit): Includes blood type and Rh status, complete blood count (CBC) for anemia, antibody screen, and infectious disease screening for rubella immunity, syphilis, Hepatitis B, HIV, Hepatitis C (risk-based or universal), chlamydia, and gonorrhea.
- Carrier Screening (Pre-conception and Initial Prenatal Visit): Blood or saliva tests to determine if an individual or couple carries a gene for certain inherited disorders. The American College of Obstetricians and Gynecologists (ACOG) recommends offering screening for spinal muscular atrophy (SMA) and cystic fibrosis (CF) to all pregnant individuals, and hemoglobinopathy screening based on ethnicity or risk factors.
- Combined First-Trimester Screen (FTS) (Weeks 11-14): A screening test for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome). It involves a Nuchal Translucency (NT) ultrasound (measuring fluid at the back of the fetal neck) and a maternal blood test for PAPP-A and hCG.
- Cell-Free DNA (cfDNA) Screening / Non-Invasive Prenatal Testing (NIPT) (From 10 weeks gestation): A maternal blood test that analyzes fragments of fetal DNA in the mother's bloodstream. It has a high detection rate for common trisomies and can also screen for sex chromosome aneuploidies and certain microdeletions. ACOG considers cfDNA the most sensitive and specific screening test for common aneuploidies.
- Chorionic Villus Sampling (CVS) (Weeks 10-13): A diagnostic test where a sample of placental tissue is taken. It provides a definitive diagnosis for chromosomal and genetic conditions but does not detect neural tube defects.
- Quadruple (Quad) Screen (Weeks 15-22): A maternal blood screening test for Trisomies 21 and 18, and neural tube defects (NTDs) like spina bifida, by measuring four markers: AFP, hCG, uE3, and inhibin A.
- Fetal Anatomy Survey / Anatomy Ultrasound (Weeks 18-22): A detailed ultrasound examination of fetal structures, including the brain, heart, spine, and limbs, to detect major structural abnormalities.
- Amniocentesis (From 15 weeks onward): A diagnostic test where a sample of amniotic fluid is withdrawn. It provides a definitive diagnosis for chromosomal and genetic conditions, as well as neural tube defects (by measuring AFP in the fluid).
- Gestational Diabetes Mellitus (GDM) Screening (Weeks 24-28): Involves either a one-step 75-g oral glucose tolerance test (OGTT) or a two-step approach starting with a 50-g glucose challenge test (GCT) followed by a 100-g OGTT if the GCT is abnormal.
- Group B Streptococcus (GBS) Screening (Weeks 36-37): A vaginal and rectal swab to identify carriers who will need antibiotics during labor to prevent neonatal GBS infection.
- Repeat Complete Blood Count (CBC) (Third Trimester): To check for anemia.
- Fetal Well-being Assessment (Third Trimester, for high-risk pregnancies): Includes Nonstress Test (NST) to monitor fetal heart rate, Biophysical Profile (BPP) using ultrasound to assess fetal breathing, movement, muscle tone, and amniotic fluid volume, and Doppler Ultrasound to measure blood flow.
Frequently Asked Questions
What is the difference between a screening test and a diagnostic test?
A screening test estimates your risk of a condition and does not provide a definitive diagnosis. A 'high-risk' or 'positive' screening result means further testing is needed. A diagnostic test provides a definitive 'yes' or 'no' answer about whether a specific condition is present.
Are prenatal screening tests mandatory?
No, prenatal screening tests are not mandatory. Healthcare providers offer these tests to help you make informed decisions about your pregnancy care. You have the right to decline any genetic testing.
Which screening test for Down syndrome is the most accurate?
Cell-Free DNA (cfDNA) screening, also known as Non-Invasive Prenatal Testing (NIPT), has the highest detection rate for common trisomies, including Down syndrome, often exceeding 99%.
What are the risks of amniocentesis and CVS?
Both amniocentesis and Chorionic Villus Sampling (CVS) are invasive diagnostic tests that carry a small risk of procedure-related miscarriage, estimated to be around 1 in 300 to 1 in 500 for amniocentesis and slightly higher for CVS (around 1 in 200). Other rare risks include infection, amniotic fluid leakage, vaginal bleeding, and Rh sensitization (preventable with medication).
If my screening test is 'high-risk', does that mean my baby has a problem?
No, a 'high-risk' or 'positive' screening test result does not mean your baby definitely has a problem. It means there is an increased chance, and further diagnostic testing is recommended to get a definitive answer. Screening tests can sometimes have 'false positives,' indicating a high risk when the baby is unaffected.
What is a 'false positive' result?
A 'false positive' result occurs when a screening test indicates a high risk for a condition, but the fetus is actually unaffected. This can cause anxiety and may lead to decisions to undergo invasive diagnostic testing.
Why is NIPT (cell-free DNA) not considered a diagnostic test?
NIPT is a highly accurate screening test, but it analyzes fragments of fetal DNA in the mother's blood, which are not direct fetal cells. Therefore, it estimates risk rather than providing a definitive diagnosis. A diagnostic test like CVS or amniocentesis, which analyzes fetal cells directly, is needed for a confirmed diagnosis.
Can I decline all genetic testing?
Yes, you have the right to decline any genetic testing offered during pregnancy. Your healthcare provider will discuss the benefits and limitations of each test to help you make an informed decision that is right for you.
What does the anatomy ultrasound look for?
The anatomy ultrasound, typically performed between 18 and 22 weeks, is a detailed examination of the baby's structures, including the brain, heart, spine, and limbs, to detect major structural abnormalities.
Can an ultrasound detect all possible birth defects?
While a detailed anatomy ultrasound examines many fetal structures to detect major abnormalities, it cannot detect all possible birth defects. Some conditions may not be visible on ultrasound or may develop later in pregnancy.
Why do I need to be tested for gestational diabetes?
Gestational diabetes mellitus (GDM) is a type of diabetes that develops during pregnancy. Screening is done to identify GDM early, as it can lead to complications for both you and your baby if not managed. Early detection allows for treatment to help ensure a healthier pregnancy outcome.
What is Group B Strep and why is the test done so late in pregnancy?
Group B Streptococcus (GBS) is a common bacterium that can live in the vagina or rectum. While usually harmless to adults, it can cause serious infection in newborns if passed during birth. The test is done late in pregnancy (between 36 and 37 weeks) to identify carriers who will need antibiotics during labor to prevent infection in the baby.
Can I find out the baby's sex from NIPT or an ultrasound?
Yes, both Cell-Free DNA (cfDNA) screening (NIPT) and the anatomy ultrasound can often determine the baby's sex. NIPT can screen for sex chromosome aneuploidies, which involves analyzing fetal sex chromosomes, and ultrasound directly visualizes fetal anatomy.
Does my age (over 35) mean I have to have an amniocentesis?
No, being over 35 does not mean you have to have an amniocentesis. While advanced maternal age increases the risk for fetal chromosomal abnormalities, current guidelines recommend that all pregnant individuals be offered both screening and diagnostic testing options, regardless of age. You can discuss your options with your healthcare provider.
What is carrier screening and should my partner be tested?
Carrier screening is a blood or saliva test that determines if you carry a gene for certain inherited disorders, such as cystic fibrosis or spinal muscular atrophy. If you are found to be a carrier, your partner may also be tested to determine the risk of your baby inheriting the condition.
What happens if a test result shows a problem? What are my options?
If a test result shows a potential problem, your healthcare team will provide genetic counseling and detailed information. Your options may include further testing, discussing potential in-utero treatments, planning for delivery at a specialized hospital, or preparing your family and medical team for the birth of a child with specific needs. You will be supported in making informed decisions about your pregnancy.
Are ultrasounds safe for the baby? How many will I have?
Diagnostic ultrasound has been used for decades and is considered safe with no confirmed adverse effects on the fetus when used appropriately. The number of ultrasounds you will have depends on your individual pregnancy and any specific medical needs or concerns.
What is nuchal translucency (NT)?
Nuchal translucency (NT) is a measurement taken during a first-trimester ultrasound. It measures the fluid-filled space at the back of the fetal neck. An increased NT measurement can be a marker for chromosomal abnormalities like Down syndrome, as well as other conditions.
What is a 'no-call' result on an NIPT test?
A 'no-call' result on an NIPT test means that there was not enough fetal DNA in your blood sample to provide a reliable result. This can be more common with higher maternal BMI. If this happens, your healthcare provider may recommend a redraw or suggest alternative testing options.
If I had a healthy pregnancy before, do I still need all these tests?
Recommendations for pregnancy-related testing apply to each pregnancy. While a previous healthy pregnancy is reassuring, new risk factors can emerge, or conditions can occur in any pregnancy. Your healthcare provider will discuss which tests are recommended for your current situation.